Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Endra Life Sciences Inc (NQ: NDRA )

0.2620 -0.1080 (-29.19%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 415,256
Open 0.3630
Bid (Size) 0.2701 (9)
Ask (Size) 0.2800 (10)
Prev. Close 0.3700
Today's Range 0.2612 - 0.3676
52wk Range 0.2612 - 2.790
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Performance

YTD
-83.52%
-83.52%
1 Month
-75.74%
-75.74%
3 Month
-78.87%
-78.87%
6 Month
-75.05%
-75.05%
1 Year
-86.21%
-86.21%

More News

Read More
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Preview For ENDRA Life Sciences
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
NDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q4 2023
Via InvestorPlace
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Scheduled For March 28, 2024
Via Benzinga
ENDRA Life Sciences Installs First TAEUS System in the UK
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.